glp 1 and sleep apnea Episode 75- drugs Glp-1/Zepbound for Sleep Apnea Treatment

Liakos CI, Papadopoulos DP, Sanidas EA, Markou MI, Hatziagelaki EE, Grassos CA, et al

The basal GLP-1 secretion in the low-glucose (0.1 mM) state was significantly inhibited by ESI-09, or ESI-09 with H-89, and was stimulated only by 007-AM, a selective EPAC activator (Fig

p -value 0.3462]), and semaglutide (RR 1.9181 [95% CI 0.2354, 7.8184

Meta-analyses of clinical trials show that GLP-1 RAs, particularly semaglutide, lead to moderate but clinically meaningful reductions in body weight among adolescents with obesity

GLP-1 drugs work by mimicking the hormone and keeping it around longer, which can aid in appetite suppression